Business · 10/03/2004Updated: 10/17/2026 · 1 min read
FDA Revokes Certain Sections of Regulation on 30-Month Drug Approval Stays
Summary
The Food and Drug Administration (FDA) is revoking sections of its regulation concerning 30-month stays of approval for certain new drug applications, following the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, which superseded these provisions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →